In accordance with ACCME requirements, Penn State College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Chair
Arjun Balar, MD
Associate Professor of Medicine
Director, Genitourinary Medical Oncology Program
Laura and Isaac Perlmutter Cancer Center
NYU Langone Health
New York, New York

Arjun Balar, MD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for AstraZeneca/MedImmune; Genentech, Inc.; Incyte Corporation; Janssen Pharmaceuticals, Inc.; Merck & Co.; Nektar Therapeutics; Pfizer Inc.; and Seattle Genetics, Inc.
Grant/Research Support from AstraZeneca/MedImmune; Genentech, Inc.; Immunomedics; Merck & Co., Inc.; Nektar Therapeutics; and Seattle Genetics, Inc. (Research funding to Institution for all except Nektar).
Other Financial or Material Support from Merck & Co., for Steering/Scientific Advisory Committee and Nektar Therapeutics for Steering Committee Membership. AstraZeneca/MedImmune; Genentech, Inc.; and Merck & Co., Inc. for speaking engagements.

Faculty
Petros Grivas, MD, PhD
Associate Professor, Department of Medicine, Division of Oncology
Clinical Director, Genitourinary Cancers Program
University of Washington
Associate Member, Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, Washington

Petros Grivas, MD, PhD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for AstraZeneca; EMD Serono, Inc.; Exelixis, Inc.; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Genzyme Corporation; GlaxoSmithKline; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Mirati Therapeutics, Inc.; Pfizer; and Seattle Genetics, Inc.
Grant/Research Support from Bavarian Nordic; Bristol Myers Squibb; Clovis Oncology; Debiopharm Group; Immunomedics; Kure It Cancer Research; Merck & Co., Inc.; Pfizer, Inc; and QED Therapeutics.

Peter H. O’Donnell, MD
Associate Professor of Medicine
Section of Hematology/Oncology, Department of Medicine
The University of Chicago
Chicago, Illinois

Peter H. O’Donnell, MD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Merck & Co., Inc.
Grant/Research Support from Acerta Pharma; AstraZeneca/MedImmune; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Genetech, Inc./F. Hoffmann-La Roche Ltd.; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; and Seattle Genetics, Inc. Research funding goes to Institution.
Honoraria from Astellas Pharma US, Inc.; Atheneum Partners; The Dedham Group, LLC; Genetech, Inc./F. Hoffmann-La Roche Ltd.; Health Advances LLC; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; MJH Life Sciences; and Seattle Genetics, Inc.
Stock Shareholder in Allergan.
Other Financial or Material Support Travel reimbursement from Genetech, Inc./F. Hoffmann-La Roche Ltd.; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; and Seattle Genetics, Inc./Astellas Pharma US, Inc.
Other support from Janssen Pharmaceuticals, Inc.; Nektar; and National Institutes of Health.

Medical Director
Carmine DeLuca
PVI, PeerView Institute for Medical Education

Carmine DeLuca has no financial interests/relationships or affiliations in relation to this activity.

Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.

Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer’s product labeling.